newdrugapprovals.org
Genmab: Daratumumab Granted Fast Track Designation By FDA
Monoclonal antibody 2/4/2013 Genmab A/S announced that the US Food and Drug Administration has granted Fast Track designation for daratumumab. This designation covers patients with mu…